Qualitative and Quantitative Assessment of Marginal Bone Loss Following Flapless Guided Versus Conventional Implant Placement
Qualitative and Quantitative Assessment of Marginal Bone Loss Following Flapless Guided Versus Conventional Implant Placement Using Cone Beam Computed Tomography - A Split-Mouth Randomized Controlled Trial.
Marginal bone preservation is an important determinant of long-term implant success. Conventional flap implant placement provides direct visualization of the surgical site but may disturb the periosteal blood supply and contribute to early crestal bone remodeling.
Flapless guided implant placement is a minimally invasive approach that aims to preserve soft tissue architecture and vascular integrity. CBCT allows three-dimensional evaluation of peri implant bone levels, including mesial, distal, buccal, and lingual aspects.
Aim: The aim of this study was to compare flapless guided implant placement with conventional flap implant placement in terms of marginal bone loss, implant stability, postoperative pain, and soft-tissue healing.
研究概览
地位
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Ajman Emirate
-
Ajman、Ajman Emirate、阿拉伯联合酋长国、00000
- Gulf Medical University
-
-
参与标准
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
描述
Inclusion Criteria:
- Patients aged 20 years or older.
- Patients requiring at least two dental implants within the same arch.
- Patients with good general health and able to undergo oral surgery.
- Patients willing to participate in the study and provide informed consent.
- Patients with adequate bone volume for implant placement as determined by preoperative radiographic assessment (e.g., cone beam computed tomography).
Exclusion criteria:
- Patients with systemic diseases that could compromise healing or implant success (e.g., uncontrolled diabetes, immunocompromised conditions).
- Patients with a history of radiation therapy to the head and neck region.
- Patients with active periodontal disease or untreated oral infections.
- Patients who are pregnant or breastfeeding.
- Patients with a history of bisphosphonate therapy or other medications that may affect bone metabolism.
- Smoker Patients with a history of smoking or heavy alcohol consumption.
- Patients with unrealistic expectations or inability to comply with postoperative care instructions.
- Patients with significant facial trauma or anatomical deformities affecting the implant site.
- Patient who requires Immediate implant placement
- Thin gingival biotype
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:单组作业
- 屏蔽:单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Flapless Guided Implant Placement
|
a minimally invasive dental implant procedure where a surgical guide, often created using advanced imaging techniques like cone-beam computed tomography (CBCT) and computer-aided design (CAD), directs the precise placement of dental implants without the need for traditional flap elevation.
|
|
实验性的:Conventional Flap Implant Placement
|
manually raising the gingival tissue during dental implant surgery, this surgical procedure involves the placement of a dental implant directly into the alveolar or basal bone during a single session followed by the placement of a healing abutment without the use of surgical guides or advanced technology.
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Marginal Bone Loss
大体时间:baseline, 3 months, 6 months
|
CBCT assessment
|
baseline, 3 months, 6 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Implant Stability ISQ
大体时间:baseline, 3 months, 6 months
|
Implant stability was assessed as a secondary outcome using Resonance Frequency Analysis (RFA), which provides an objective and non-invasive measurement of implant stability expressed as the Implant Stability Quotient (ISQ).
|
baseline, 3 months, 6 months
|
|
Postoperative Pain Assessment VAS scale 0-10
大体时间:baseline, Day 2 Day 3 Day 4 Day 5
|
VAS scale 0-10
|
baseline, Day 2 Day 3 Day 4 Day 5
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- AbdallahMDSperio
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.